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Abstract 
 
Mandelate racemase (MR), a member of the enolase superfamily, catalyzes 
the Mg2+-dependent interconversion of the enantiomers of mandelate. Several 
α-keto acids are modest competitive inhibitors of MR [e.g., mesoxalate (Ki = 
1.8 ± 0.3 mM) and 3-fluoropyruvate (Ki = 1.3 ± 0.1 mM)], but, surprisingly, 
3-hydroxypyruvate (3-HP) is an irreversible, time-dependent inhibitor 
(kinact/KI = 83 ± 8 M–1 s–1). Protection from inactivation by the competitive 
inhibitor benzohydroxamate, trypsinolysis and electrospray ionization tandem 
mass spectrometry analyses, and X-ray crystallographic studies reveal that 3-
HP undergoes Schiff-base formation with Lys 166 at the active site, followed 
by formation of an aldehyde/enol(ate) adduct. Such a reaction is 
unprecedented in the enolase superfamily and may be a relic of an activity 
possessed by a promiscuous progenitor enzyme. The ability of MR to form and 
deprotonate a Schiff-base intermediate furnishes a previously unrecognized 
mechanistic link to other α/β-barrel enzymes utilizing Schiff-base chemistry 
and is in accord with the sequence- and structure-based hypothesis that 
members of the metal-dependent enolase superfamily and the Schiff-base-
forming N-acetylneuraminate lyase superfamily and aldolases share a 
common ancestor. 
One of the first enzyme superfamilies recognized was the 
enolase superfamily,1 whose members share a common partial 
reaction (i.e., the metal-assisted, Brønsted-base-catalyzed abstraction 
of the α-proton from a carboxylate substrate to form an enolate)2-5 
and a common protein fold [i.e., a modified (α/β)8-barrel (TIM barrel) 
bearing the catalytic residues at the C-terminal ends of the β-strands 
and an N-terminal domain that caps the active site conferring 
substrate specificity and excluding solvent].6-8 Studies of members of 
the enolase superfamily have afforded important insights into enzyme 
evolution and developing strategies for assigning the correct functions 
to proteins identified in genome projects.3,9-12 The well-characterized 
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archetype of this superfamily, mandelate racemase (MR, EC 5.1.2.2) 
from Pseudomonas putida, catalyzes the Mg2+-dependent, 1,1-proton 
transfer reaction that interconverts the enantiomers of mandelate and 
has served as a useful paradigm for understanding how enzymes 
catalyze the rapid α-deprotonation of a carbon acid substrate with a 
relatively high pKa value.13 
 
MR utilizes a two-base mechanism with Lys 166 and His 297 
abstracting the α-proton from (S)- and (R)-mandelate, respectively 
(Scheme 1). A variety of β/γ-unsaturated compounds,14-21 as well as 
trifluorolactate,22 serve as substrates for the enzyme. Recently, we 
showed that the substrate–product analogue 3,3,3-trifluoro-2-
hydroxy-2-(trifluoromethyl)propionate [TFHTP (Chart 1)] is a potent 
competitive inhibitor of MR (Ki = 27 μM) and that its unexpectedly high 
binding affinity arises from both intimate interactions between the 
trifluoromethyl groups and the hydrophobic pocket at the active site, 
and formation of salt bridges between the carboxylate of TFHTP and 
the active site Brønsted acid–base catalysts Lys 166 and His 297.23 
Recognizing that these active site bases can be exploited as binding 
determinants for inhibitors, we showed that tartronate is also a 
competitive inhibitor of MR (Ki = 1.8 mM), binding with its glycolate 
moiety chelating the Mg2+ ion and with the remaining carboxylate 
group interacting with and bridging the active site Brønsted acid–base 
catalysts.23 Our interest in understanding the role of the active site 
Brønsted acid–base catalysts as binding determinants led us to 
interrogate the active site using three-carbon α-keto acids as 
tartronate analogues. Most unexpectedly, we discovered that 3-
hydroxypyruvate (3-HP) is an irreversible inhibitor of MR, reacting at 
the active site to form a Schiff-base intermediate that is subsequently 
deprotonated to form an aldehyde/enol(ate) adduct. Such a reaction 
has not been reported previously for any member of the enolase 
superfamily and suggests a mechanistic link to other enzyme 
superfamilies utilizing Schiff-base chemistry. 
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Chart 1. Structures of Ligands 
 
 
Scheme 1. Reaction Catalyzed by Mandelate Racemase 
Materials and Methods 
General 
 
(R)-Mandelic acid, lithium 3-hydroxypyruvate (3-HP), sodium 
mesoxalate monohydrate, benzoylformic acid, sodium pyruvate, 
benzohydroxamic acid, sodium 3-fluoropyruvate monohydrate (3-FP), 
and all other reagents, unless mentioned otherwise, were purchased 
from Sigma-Aldrich Canada Ltd. Circular dichroism (CD)-based assays 
were conducted using a JASCO J-810 spectropolarimeter with a 
thermostated, water-jacketed cell holder. High-resolution electrospray 
ionization (ESI) mass spectrometry (MS) was conducted using a 
Brüker microTOF Focus orthogonal ESI-time-of-flight mass 
spectrometer operating in positive ion mode. 
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Concentration Correction for 3-HP 
 
Elemental analysis (Canadian Microanalytical Services Inc.) was 
conducted on the lithium salt of 3-HP purchased from Sigma-Aldrich to 
obtain an accurate estimate of the extent of hydration. On the basis of 
the presence of 26.13% carbon and 3.63% hydrogen in the sample, 
the calculated molecular weight of 3-HP was 137.89, which 
corresponds to C3H3O4Li·∼1.5H2O. 
 
Site-Directed Mutagenesis 
 
The pET52b(+)-wtMR plasmid24 was used as the template to 
create the H297N mandelate racemase (MR) mutant by performing 
polymerase chain reaction (PCR)-based site-directed mutagenesis 
using the QuikChange Site-directed Mutagenesis Kit (Stratgene) and 
following the protocols described by the manufacturer. Polymerase 
chain reactions were conducted using PfuTurbo DNA polymerase (Bio 
Basic Inc.). The forward and reverse synthetic deoxyoligonucleotide 
primers (Integrated DNA Technologies, Inc.) used to construct the 
mutant were 5′-CCAATGTCCAGCAACCTGTTCCAAGAAATCAGC-3′ and 
5′-GCTGATTTCTTGGAACAGGTTGCTGGACATTGG-3′, respectively. The 
codons specifying the relevant amino acid are underlined, and the 
altered bases are given in boldface. Potential mutant plasmids were 
used to transform competent Escherichia coli DH5α cells. DH5α cells 
were used for plasmid maintenance and for all sequencing reactions. 
The mutant open reading frame was sequenced using commercial 
automated DNA sequencing (Robarts Research Institute) to ensure 
that no other alterations of the nucleotide sequence had been 
introduced. 
 
Enzyme Purification 
 
Recombinant wild-type (wtMR) and H297N MR from 
Pseudomonas putida were overexpressed in and purified from E. coli 
BL21(DE3) cells transformed with the pET-52b(+)-wtMR and pET-
52b(+)-H297N-MR plasmids, respectively. The pET-52b(+)-wtMR 
plasmid containing the MR variant open reading frame encodes the MR 
gene product (MASWSHPQFEKGALEVLFQGPGYHM1...MR) with an N-
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terminal StrepII tag (underlined; M1 represents the first amino acid of 
wild-type MR).24 The wild-type and mutant enzymes were purified by 
affinity chromatography using Strep-Tactin Superflow resin (IBA 
GmbH) and an ÄKTA FPLC instrument (GE Healthcare) as described 
previously.24 Upon elution from the column, the enzyme was dialyzed 
against storage buffer [100 mM HEPES buffer (pH 7.5) containing 3.3 
mM MgCl2, 200 mM NaCl, and 10% (v/v) glycerol] and stored at 
−20 °C. The purity of the enzyme preparation (≥99%) was checked 
using 12% sodium dodecyl sulfate–polyacrylamide gel electrophoresis 
(SDS–PAGE). StrepII-tagged MR has the same activity as the wild-
type enzyme;24 consequently, the StrepII tag was not removed from 
the enzymes. 
 
Enzyme Assays 
 
MR activity was assayed using a CD-based assay by following 
the change in ellipticity of mandelate at 262 nm using a thermostated 
quartz cuvette with a 1-cm light path (unless otherwise indicated) as 
described by Sharp et al.25 All assays (total volume of 2 mL) were 
conducted at 25 °C in Na+-HEPES buffer (0.1 M, pH 7.5) containing 
MgCl2 (3.3 mM), BSA [0.005% (w/v)], and (R)-mandelate as the 
substrate. The concentration of MR was determined from its 
absorbance at 280 nm using an extinction coefficient of 53400 M–1 cm–
1, which was calculated using the ProtParam tool available on the 
ExPASy server (http://web.expasy.org/protparam).26 All kinetic 
parameters were determined in triplicate, and average values are 
reported. The reported errors are the standard deviations. 
 
Initial Screening of α-Keto Acids for Time-Dependent 
Inhibition of MR 
 
Wild-type MR (32.7 nM) was incubated with either pyruvate 
(10.0 μM), mesoxalate (10.0 μM), 3-FP (10.0 μM), benzoylformate 
(10.0 μM), or 3-HP (8.0 μM) in the presence of BSA [0.05% (w/v)] at 
25 °C for 0, 6, 12, 18, and 24 min. At each time point, 200 μL of the 
enzyme/inhibitor mixture was added to assay buffer containing (R)-
mandelate to determine the MR activity. The residual MR activity was 
measured using the CD-based assay by following the change in 
ellipticity of mandelate at 262 nm for 3 min in a quartz cuvette with a 
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1-cm light path (0.5-cm light path length when the inhibition by 
benzoylformate was assessed). The final concentrations of MR, BSA, 
inhibitor, and (R)-mandelate in the 2.0 mL assay mixture were 3.3 nM, 
0.005% (w/v), 1.0 μM (except for that of 3-HP, which was 0.8 μM), 
and 10 mM, respectively. Simultaneously, a control reaction mixture 
containing wild-type MR (32.7 nM) was incubated in assay buffer at 
25 °C for 0 and 30 min to determine the rate of loss of MR activity 
under the incubation conditions in the absence of inhibitor. Similar 
time-dependent inhibition experiments were also conducted for 
pyruvate, mesoxalate, benzoylformate, and 3-FP at a greater inhibitor 
concentration (2 mM) for 0 and 10 min. The final concentrations of 
MR, inhibitor, and (R)-mandelate were equal to 3.3 nM, 0.2 mM, and 
10 mM, respectively, in a total reaction volume of 2.0 mL for the 
activity assays. 
 
Inhibition of MR by Mesoxalate and 3-FP 
 
Inhibition experiments were conducted in Na+-HEPES buffer (0.1 
M, pH 7.5) containing MgCl2 (3.3 mM), BSA [0.005% (w/v)], (R)-
mandelate (0.25–10.0 mM), MR (3.0 nM), and either mesoxalate (0, 
1.0, 2.0, and 4.0 mM) or 3-FP (0, 0.75, 1.5, and 3.0 mM) in a total 
reaction volume of 2.0 mL. The apparent kinetic constants Vmax and Km 
were determined by fitting eq 1 to the initial velocity data using 
nonlinear regression analysis and KaleidaGraph version 4.02 from 
Synergy Software. Competitive inhibition constants (Ki) were 
determined from plots of the apparent Km/Vmax values versus inhibitor 
concentration in accord with eq 2. 
 
(1) 
 
(2) 
 
Inactivation of MR by 3-HP 
 
The kinetic parameters for the time-dependent inhibition of MR 
by 3-HP were determined by incubating wild-type MR (32.7 nM) with 
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various concentrations of 3-HP (0, 3.99, 7.98, 11.97, and 15.95 μM) in 
the presence of BSA [0.05% (w/v)] at 25 °C for 0, 6, 12, 18, and 24 
min. At each time point, an aliquot (200 μL) of the reaction mixture 
was added to the assay solution (total volume of 2.0 mL) containing 
(R)-mandelate (final concentration of 10 mM) to determine the 
remaining MR activity as described above. The observed pseudo-first-
order rate constant for the inactivation of MR (kobs) at each inhibitor 
concentration was determined by fitting eq 4 (based on eq 3) to the 
data for the loss of MR activity as a function of time. The values of kobs 
were then plotted against the concentration of 3-HP to determine the 
efficiency of inactivation (kinact/KI) using eq 6 (based on eq 5, because 
[3-HP] ≪ KI). Because saturation was not observed, only the apparent 
second-order rate constant (k2 or kinact/KI) could be determined. 
 
(3) 
 
(4) 
 
(5) 
 
(6) 
 
MR (32.7 nM) that had been completely inactivated by 3-HP (15.95 
μM) was dialyzed for 4.5 and 10.5 h at 4 °C against HEPES assay 
buffer (pH 7.5) to test the reversibility of the inhibition. After dialysis, 
no significant MR activity was regained relative to that of a control 
sample containing wild-type MR in the absence of 3-HP. 
 
Inactivation of MR by 3-HP in the Presence of 
Benzohydroxamate (BzH) 
 
MR (32.71 nM) was incubated with 3-HP (15.95 μM) in the 
presence BSA [0.05% (w/v)] and various concentrations of BzH (0, 5, 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biochemistry, Vol 54, No. 17 (May 5, 2015): pg. 2747-2757. DOI. This article is © American Chemical Society and 
permission has been granted for this version to appear in e-Publications@Marquette. American Chemical Society does 
not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission 
from American Chemical Society. 
9 
 
10, and 20 μM) at 25 °C. At various time points (0, 6, 12, 18, and 24 
min), an aliquot (200 μL) of the reaction mixture was added to the 
assay solution (total volume of 2.0 mL) containing (R)-mandelate 
(final concentration of 10 mM) to determine the amount of MR activity 
remaining as described above. The observed pseudo-first-order rate 
constants for the inactivation of MR (kobs) by 3-HP (15.95 μM) in the 
presence of various concentrations of BzH were determined by fitting 
eq 4 to the data for loss of MR activity as a function of time. 
 
Mass Spectrometry Analysis of MR Inactivated by 3-HP 
 
Wild-type MR (0.7 mg/mL) and H297N MR (0.98 mg/mL) were 
incubated with 3-HP (4.0 mM) at 25 °C until the activity of wild-type 
MR was undetectable using the CD-based assay [assay concentrations 
of MR and (R)-mandelate of 327 nM and 10 mM, respectively]. A 
control sample containing wild-type MR was incubated for the same 
time period in the absence of 3-HP. After complete inactivation of wild-
type MR by 3-HP, an aliquot (20 μL) was removed from each reaction 
mixture and subjected to SDS–PAGE (12%). 
 
In-Gel Digestions 
 
Gel bands from SDS–PAGE corresponding to MR and H297N MR 
were excised from the gel and rinsed with deionized water (2 × 300 
μL). The excised gel strips were then cut into cubes (∼1 mm3) and 
processed using an automated system for conducting in-gel protein 
digestions (Investigator Progest, Genomic Solutions). Briefly, the 
protein in the gel cubes was reduced using dithiothreitol (10 mM), 
carboxamidomethylated using iodoacetamide (100 mM), and digested 
for 12 h at 37 °C using sequencing-grade trypsin (Promega). The 
peptides were extracted from the gel pieces by three 20 min 
incubations with a solution (30 μL) containing acetonitrile (50%) and 
formic acid (5%) in LC–MS-grade water with gentle agitation. The 
extracts were pooled and dried using a vacuum concentrator (Speed 
Vac Concentrator, SPD 111 V-230, Thermo Electron Corp.) and finally 
resuspended in LC–MS-grade water (15 μL) containing acetonitrile 
(3%) and formic acid (0.5%). 
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LC–ESI-MS/MS and Data Analysis 
 
LC–ESI-MS/MS was conducted using a nanoflow HPLC system 
(UltiMate 3000, Dionex) connected to a hybrid ion trap-orbitrap high-
resolution tandem mass spectrometer (Velos Pro, Thermo Scientific) 
operated in data-dependent acquisition (DDA) mode. Each sample (1 
μL) was injected onto a capillary column (C18 Onyx Monolithic, 0.10 
mm × 150 mm, Phenomenex) at a flow rate of 300 nL/min. Samples 
were sprayed at 1.6 kV using fused silica noncoated emitters (20 μm 
inside diameter with a 10 μm ID tip, PicoTip Emitter from New 
Objective). Chromatographic separation was achieved using a linear 
gradient from 3 to 35% solvent B in solvent A over 30 min and then 
increasing the level of solvent B to 95% over 5 min (solvent A 
consisted of 0.1% formic acid in water and solvent B 0.1% formic acid 
in acetonitrile). The raw data files were acquired (Xcalibur, Thermo 
Fisher) and exported to Proteome Discoverer software version 1.4 
(Thermo Fisher) for peptide and protein identification using the 
Sequest database search algorithm.27 Carbamidomethyl cysteine and 
oxidized methionines were selected as static and dynamic 
modifications, respectively. Peptide to spectrum match (PSM) 
validation was conducted using high-confidence XCorr threshold values 
of 1.9, 2.3, and 2.6 for doubly, triply, and more highly charged 
precursors. 
 
Analysis of H297N MR-3-HP Reduced with NaCNBH3 
 
H297N MR (0.98 mg/mL) was incubated with 3-HP (4.0 mM) in 
assay buffer at 25 °C for 30 min. Sodium cyanoborohydride (10 μL of 
a 1 M stock solution) was then added to the reaction mixture (total 
volume of 200 μL) to give a final concentration of 50 mM, and the pH 
was adjusted to 7.0 using HCl. The reaction mixture was then 
incubated for an additional 30 min. Finally, an aliquot of the reaction 
mixture (20 μL) was subjected to SDS–PAGE (12%) and analyzed 
using mass spectrometry as described above. 
 
X-ray Crystallography 
 
All crystals of wild-type MR were obtained at room temperature 
by the batch crystallization method. The protein solution consisted of 
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MR (6.0 mg/mL) purified as described above, in the presence of Na+-
HEPES buffer (50 mM, pH 7.5) containing MgCl2 (3.3 mM) and 3-HP 
(20 mM). The batch reservoir solution was composed of sodium 
acetate (140 mM, pH 4.5), KCl (280 mM), and pentaerythritol 
propoxylate 426 (PEP 426; 46%). The protein solution and reservoir 
solution were gently mixed in a 1:1 ratio to a final volume of 20 μL, 
and 10 μL of this mixture was pipetted into a lightly greased 
crystallization well and sealed with a glass coverslip lined with mineral 
oil. Crystals grew spontaneously for 17 h, resulting in hexagonally 
shaped crystals. These crystals were looped directly from the wells to 
be flash-cooled in liquid nitrogen for storage. 
 
Data Collection, Structure Determination, and 
Refinement 
 
X-ray diffraction data for MR cocrystallized with 3-HP were 
collected at the Advanced Photon Source (APS) beamline LS-CAT-21-
ID-G on a Rayonix MarMosaic 300 CCD detector, with an X-ray 
wavelength of 0.979 Å. Diffraction images were processed using 
HKL2000.28 The structure was determined by molecular replacement 
using the wild-type MR enzyme [Protein Data Bank (PDB) 2MNR] as 
the search model with Phaser.29 The molecular replacement models 
were extended by several rounds of manual model building with 
COOT30 and refinement with REFMAC31 using an automatically 
generated geometric/X-ray weighting term. Water molecules were 
added to the model in COOT with subsequent manual verification. On 
the basis of protein purification conditions and the well-established 
metal binding preference of MR, a Mg2+ ion was modeled into the 
active site, despite the fact that a modeled Mg2+ ion does not satisfy 
all of the observed electron density at this position. 
Results and Discussion 
Structure–Activity Study 
 
We examined the effect of the α-keto acids 3-HP, mesoxalate, 
3-fluoropyruvate (3-FP), and pyruvate on MR activity (Chart 1). 
Mesoxalate, which is fully hydrated in water (i.e., C2 gem-diol),32 was 
a competitive inhibitor of MR with respect to (R)-mandelate [Ki = 1.8 
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± 0.3 mM (Figure 1S of the Supporting Information)], binding with the 
same affinity as tartronate (Ki = 1.8 mM),23 suggesting that the 
glycolate-like moiety present in both ligands chelates the Mg2+ and the 
second carboxylate forms a salt bridge with the active site Brønsted 
acid–base catalysts, thereby compensating for the loss of hydrophobic 
interactions.23 Pyruvate, which exists as the keto form under the assay 
conditions,33,34 exhibited only 40% inhibition of MR activity at a 
concentration of 25 mM [i.e., Ki ≈ 20 mM, assuming competitive 
inhibition with 1 mM (R)-mandelate; Km = 1.2 mM]. This low binding 
affinity is similar to that of lactate (Ki ≈ 30 mM)20 and likely arises 
because the methyl group is not sufficiently hydrophobic, nor can it 
form salt bridges with the Brønsted acid–base catalysts. MR bound 3-
FP with an affinity [Ki = 1.3 ± 0.1 mM (Figure 2S of the Supporting 
Information)] ∼15-fold greater than the affinity it exhibited for 
pyruvate, due to either dipolar interactions (rather than true H-
bonds)35,36 with the active site acid–base catalysts or enhanced 
hydrophobic interactions.37 
 
In aqueous solutions, α-keto acids can exist as hydrates (gem-
diols) to varying degrees.33 The hydration state will determine the 
hybridization of C2 and could affect the binding of α-keto acids at the 
active site of MR. Pyruvate exists as the keto form (>92%) at pH 
6.8,33,34 and benzoylformate (an α-keto acid examined previously)38 is 
also expected to be in the keto form (>90%) at the assay pH.39 Our 
observations that MR binds pyruvate (Ki ∼ 20 mM) and benzoylformate 
(Ki = 0.65 mM)38 with affinities similar to those for lactate (Ki = 30 
mM)20 and (R)-mandelate (Km = 0.81 mM),38 respectively, suggest 
that the enzyme does not distinguish between sp2 and sp3 
hybridization at C2 in the ground state. Mesoxalate and 3-FP are 100% 
and >90% hydrated, respectively, in aqueous solutions.32,40-42 
However, in the active site of MR, it is possible that coordination of the 
metal ion could lead to dehydration of the gem-diols, yielding the 
corresponding keto species.43 It is unlikely, however, that this latter 
possibility would result in a significant alteration of the binding affinity 
considering our observations with pyruvate and lactate, and 
benzoylformate and mandelate, mentioned above. 
  
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biochemistry, Vol 54, No. 17 (May 5, 2015): pg. 2747-2757. DOI. This article is © American Chemical Society and 
permission has been granted for this version to appear in e-Publications@Marquette. American Chemical Society does 
not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission 
from American Chemical Society. 
13 
 
Inactivation by 3-HP 
 
Surprisingly, 3-HP (8.0 μM) showed time-dependent inhibition, 
while the other α-keto acids did not show such behavior at a 
concentration of 10 μM (Figure 1a) or 2 mM (Figure 3S of the 
Supporting Information). Dialysis of the inactive 3-HP-treated MR 
against assay buffer for ∼11 h did not restore enzymatic activity, 
indicating that the inactivation was irreversible. The inactivation of MR 
by 3-HP followed pseudo-first-order kinetics (Figure 1b), and the 
observed pseudo-first-order rate constants (kobs) exhibited a linear 
dependence on the concentration of 3-HP (Figure 1c). Saturation was 
not observed at 3-HP concentrations of ≤16 μM, and at higher 
concentrations of 3-HP, we were not able to obtain accurate kobs values 
because the loss of the MR activity was too rapid (relative to the assay 
duration of 3 min). Consequently, we were not able to differentiate 
between a kinetic mechanism for inactivation following a single step 
and a two-step mechanism with the reversible formation of a binary 
complex between MR and 3-HP. The slope from the plot of kobs versus 
the concentration of 3-HP gave an apparent second-order rate 
constant for inactivation (kinact/KI or k2) with a value of 83 ± 8 M–1 s–1. 
The observed rate of inactivation by 3-HP was reduced in the presence 
of the reversible competitive inhibitor benzohydroxamate (BzH) 
(Figure 1d), indicating that 3-HP likely binds at the active site. 
 
 
Figure 1. Time-dependent inhibition of MR activity. (a) Time-dependent inactivation of 
MR (32.7 nM) incubated with either 3-HP (8.0 μM, ●), mesoxalate (10 μM, ▽), 
pyruvate (10 μM, □), benzoylformate (10 μM, △), 3-FP (10 μM, ◇), or no inhibitor (○) 
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at 25 °C. The reaction mixture was diluted 10-fold by addition of assay buffer 
containing (R)-mandelate (final concentration of 10 mM), and the initial rates were 
measured at the indicated times. (b) Time-dependent inactivation of MR (32.7 nM) 
incubated with various concentrations of 3-HP: 0 (●), 4.0 (▲), 8.0 (■), 12.0 (▼), and 
16.0 (◆) μM at 25 °C. The initial rates were measured at the indicated time points. (c) 
Observed pseudo-first-order rate constants for inactivation (kobs) plotted as a function 
of 3-HP concentration. The slope yields a value for the apparent second-order rate 
constant for the efficiency of inactivation (kinact/KI) equal to 83 ± 8 M–1 s–1. (d) 
Protection against 3-HP-dependent inactivation of MR by 0 (◇), 5 (△), 10 (□), and 20 
(▽) μM benzohydroxamate at 25 °C. MR was incubated with 3-HP (16.0 μM), and the 
initial rates were measured at the indicated time points as described above. The value 
for the control reaction, in the absence of 3-HP, is also shown (○). Experimental details 
may be found in Materials and Methods. 
Site of Covalent Modification 
 
To identify the residue(s) modified upon inactivation by 3-HP, 3-
HP-modified MR (3-HP–MR) and an untreated sample of MR (control-
MR) were subjected to SDS–PAGE followed by in-gel digestion with 
trypsin. The resulting proteolytic cleavage peptides were analyzed 
using LC–ESI-MS/MS. For both control-MR and 3-HP–MR, ≥95% 
sequence coverage was obtained. MS data showed identical peptides in 
both the control-MR and 3-HP–MR samples with the exception of the 
cleavage fragment TKIGYPALDQDLAVVR (TK-peptide, residues 165–
180 with one missed cleavage site). The TK-peptide in the 3-HP–MR 
sample gave two m/z peaks. One peak corresponded to an unmodified 
peptide (MH+, m/z 1758.97) that was also observed in control-MR, 
suggesting that either the enzyme was partially modified or some 
modification was reversed during sample preparation. The other TK-
peptide had a higher m/z value (MH+, m/z 1844.98), consistent with 
MR being modified by addition of a group with a mass of 86 Da. 
Internal fragmentation of the triply charged modified TK-peptide 
(monoisotopic, m/z 615.66) and the triply charged unmodified TK-
peptide (monoisotopic, m/z 586.99) precursors gave a mass increment 
of 86 Da between the b2+ ions arising from the modified (316.34 Da) 
and unmodified (230.27 Da) TK-peptides, suggesting modification of 
either Thr 165 or Lys 166 (Figure 2a,b). Modification of Thr 165 
seemed unlikely because the side chain of this residue is directed away 
from the active site, and it is difficult to account for the increment of 
86 Da. The remaining b and y ions corresponded to the expected 
amino acid sequence of the TK-peptides. Upon treatment of H297N MR 
with 3-HP and subsequent LC–ESI-MS/MS analysis, no modified tryptic 
peptides were observed, suggesting that His 297 is required for 
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irreversible inhibition. Thus, our kinetic and MS/MS results suggest 
that 3-HP modifies Lys 166, with the resulting adduct having a 
molecular mass of 86 Da. 
 
 
Figure 2. ESI-MS/MS analysis of TK-peptides. Mass spectra for the triply charged ion 
of the TK-peptide from (a) untreated wild-type MR (m/z 586.995; MH+ = 1758.971 
Da) and (b) 3-HP-treated wild-type MR (m/z 615.664; MH+ = 1844.976 Da) reveal 
modification of the tryptic peptide (with one missed cleavage site), increasing the 
mass by 86 Da. The increase in mass of the b2+ ion by 86 Da suggests modification of 
Lys 166 (bold in panel b). (c) ESI-MS/MS analysis of the triply charged ion (m/z 
616.329; MH+ = 1846.97 Da) of the TK-peptide (residues 165–180) arising from the 
trypsin-digested 3-HP-modified H297N MR treated with NaCNBH3 reveals modification 
of the active site Lys 166, increasing the mass by 88 Da. This mass is consistent with 
reduction of the Schiff-base adduct. 
Mechanism of Inactivation 
 
A possible mechanism accounting for our observations involves 
the reversible formation of a Schiff base (imine) between the ε-NH2 
group of Lys 166 and the α-carbonyl of 3-HP [C2 mechanism (Scheme 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biochemistry, Vol 54, No. 17 (May 5, 2015): pg. 2747-2757. DOI. This article is © American Chemical Society and 
permission has been granted for this version to appear in e-Publications@Marquette. American Chemical Society does 
not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission 
from American Chemical Society. 
16 
 
2)], similar to the mechanism proposed for the inactivation of N-
acetylneuraminate lyase (NAL)44 and dihydrodipicolinate synthase 
(DHDPS)45 by 3-HP. Subsequent deprotonation of the Schiff base 
(presumably by His 297) would yield an enol or enolate [i.e., 
enol(ate)] (86 Da), which could tautomerize to yield a covalent 
aldehyde adduct. Incubation of H297N MR with 3-HP, followed by 
treatment with NaCNBH3, and subsequent separation by SDS–PAGE 
and analysis using LC–ESI-MS/MS revealed that Lys 166 of the TK-
peptide was modified by a group with a mass of 88 Da (Figure 2c), 
consistent with reduction of the Schiff base and in accord with the 
proposed inactivation mechanism. In addition, we observed two 88 Da 
adducts arising from the nonspecific modification of Lys 207 and Lys 
238 located away from the dimer interface on the surface of the 
enzyme (data not shown). Such adducts would be expected 
considering that imines may form spontaneously at other sites bearing 
a primary amino group.46,47 
 
 
Scheme 2. Proposed Mechanisms for Inactivation of MR by 3-HP Giving Rise to an 86 
Da Adduct 
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Alternatively, 3-HP may undergo tautomerization either in 
solution or within the active site to yield tartronate semialdehyde.48 
Schiff-base formation between Lys 166 and the aldehyde [C3 
mechanism (Scheme 2)], followed by deprotonation, also yields an 
adduct with a mass of 86 Da and is consistent with our LC–ESI-MS/MS 
observations. 
 
Structural Studies 
 
To distinguish between these two mechanistic possibilities, we 
determined the X-ray crystal structure of MR inactivated by 3-HP at 
1.65 Å resolution (Table 1). The electron density clearly indicates bond 
formation occurs between the ε-NH2 group of Lys 166 and C2 of 3-HP 
in accord with the C2 mechanism (Figure 3 and Figure 4S of the 
Supporting Information). The structure was refined by defining a single 
bond between the ε-NH2 group of Lys 166 and C2 of 3-HP, and the 3-
HP adduct was further refined in two alternative conformations: major 
(70%) and minor (30%) conformations of either the (E)-enol(ate) or 
the aldehyde. Although it is not possible to determine whether the 
product adduct exists as the aldehyde or enol(ate) tautomer from the 
crystal structure, the enol(ate) may be preferred because enolase, 
which has a similar active site architecture, is strongly inhibited by the 
enolate of d-tartronate semialdehyde phosphate.49,50 Certainly, the 
active site of MR is optimized to stabilize an enolate in accord with its 
ability to catalyze racemization, and Nε2 of His 297 is 2.9 Å from the 
terminal oxygen of the major adduct so that it is capable of stabilizing 
the enol(ate) through H-bonding (Figure 3). The inability of 3-FP to 
inactivate MR indicates that the formation of either the enol(ate) or 
aldehyde by 3-HP is essential for inactivation. 
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Figure 3. X-ray structure of 3-HP–MR. (a) Stereoview of the active site showing the 
major (70%) and minor (30%) conformations of the 3-HP adduct with Lys 166. The 
aldehyde/enol(ate) oxygen of the major conformation is within H-bonding distance of 
the Brønsted acid–base catalyst His 297. (b) Stereoview of representative 2Fo – Fc 
electron density maps, contoured at 1.0σ, for the 3-HP–MR structure showing a close-
up view of the Lys 166–3-HP adduct. 
Table 1. X-ray Data Collection and Refinement Statistics 
  3-HP–MR 
PDB entry 4X2P  
space group I422 
cell dimensions   
a, b, c (Å) 123.88, 123.88, 105.30 
α, β, γ (deg) 90, 90, 90 
resolution range (Å) 50.0–1.65 (1.68–1.65)a 
redundancy 13.0 (8.4)a 
completeness (%) 99.6 (94.0)a 
no. of unique reflections 49040 
Rmerge 0.082 (0.437)a 
average I/σ 29.55 (4.125)a 
Refinement 
resolution range (Å) 40–1.65 (1.69–1.65)a 
Rcryst 0.145 (0.181)a 
Rfree 0.177 (0.232)a 
no. of protein atoms 2757 
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  3-HP–MR 
no. of water molecules 297 
Wilson B value (Å2) 17.0 
average B factor (Å2)   
protein 16.1 
ligand 23.9 
Mg2+ 2.3 
solvent 26.1 
Ramachandran plot (%)   
most favored 91.5 
additionally allowed 7.5 
generously allowed 0.7 
disallowed 0.3 
root-mean-square deviations   
bond lengths (Å) 0.028 
bond angles (deg) 2.54 
aValues in parentheses are for the highest-resolution bin. 
 
C2 of the 3-HP enamine occupies a position approximately 
equivalent to that of the α-methyl group of (S)-atrolactate (Figure 4). 
Both ground state and transition state analogues bind to MR with one 
carboxylate oxygen and the α-OH group coordinated to Mg2+ in the 
active site. In the 3-HP–MR structure, however, the α-OH group is 
replaced with a free water molecule, while one carboxylate oxygen 
maintains coordination with Mg2+ in a manner analogous to that of the 
substrate and transition state analogues. This coordination with the 
active site Mg2+ likely facilitates deprotonation of the Schiff base by His 
297, similar to its role in stabilizing the aci-carboxylate intermediate 
during the racemization of mandelate. Interestingly, the active site lid 
(20s loop) that typically closes over the active site when either ground 
state or transition state analogues are bound adopts an “open” 
conformation in the 3-HP–MR structure (Figure 5). This conformation 
may arise because the hydrophobic group (i.e., aromatic ring) present 
on substrates and intermediate analogues is not present to drive lid 
closure.51 The 20s loop in the structure of MR (PDB entry 4M6U) with 
bound tartronate, which also lacks the phenyl ring, exhibited an 
approximately 1:1 ratio of both the open and closed conformations;23 
however, it is important to note that the 20s loop of MR with only 
sulfate bound (PDB entry 2MNR) was closed, suggesting that other 
factors may also contribute to the observed conformation of the loop in 
crystals.8 
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Figure 4. Stereoview of the active site of MR containing the adduct with 3-HP (green), 
overlaid with the bound substrate analogue (S)-atrolactate [(S)-Atro; PDB entry 
1MDR, orange],(71) and the intermediate analogue benzohydroxamate (BzH; PDB 
entry 3UXK, pink).(72) The Brønsted acid–base catalysts (His 297 and Lys 166) are 
colored cyan. 
 
Figure 5. Structural overlay of the 3-HP–MR structure (colored white, with the 20s 
loop colored green) with the structures of MR in the presence of (S)-atrolactate (PDB 
entry 1MDR, orange),71 benzohydroxamate (PDB entry 3UXK, pink),72 and benzilate 
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(PDB entry 4HNC, yellow).23 Aside from 3-HP, all other ligands are not shown for the 
sake of clarity. The 3-HP–MR structure exhibits an “open” conformation of the 20s loop 
lid, similar to the conformation observed when the bulky substrate–product analogue 
benzilate is bound to C92S/C264S/K166C MR.23 
Mechanistic Link between Superfamilies 
 
The formation of a Schiff base is unprecedented in the enolase 
superfamily. However, irreversible inhibition by 3-HP has been 
demonstrated for members of the NAL superfamily. This superfamily 
includes NAL, DHDPS, trans-o-hydroxybenzylidene-pyruvate 
hydratase-aldolase, and d-4-deoxy-5-oxoglucarate dehydratase,2,7,52 
which have also been included within the class I aldolases53 by the 
SCOP database54,55 on the basis of their similar Schiff-base chemistry 
and common (α/β)8-fold. 3-HP inactivates NAL from Clostridium 
fringens56 and E. coli44 and DHDPS from E. coli,45 and the X-ray crystal 
structures of the covalently modified NAL and DHDPS enzymes 
revealed the presence of an aldehyde/enol(ate)–lysine adduct similar 
to the one we observe for MR inactivated by 3-HP.44,45 Although the 
mechanism-based inhibition of these two NAL superfamily members by 
3-HP also proceeds via initial Schiff-base formation followed by 
deprotonation,44,45 the apparent second-order rate constant for the 
inactivation of MR exceeds that observed for inactivation of DHDPS 
(0.56 M–1 s–1) by ∼138-fold. This observation is in accord with the 
active site of MR being optimized to promote enolate formation. 
 
Many of the enzymes sharing the highly prevalent (α/β)8-barrel 
(or TIM barrel) folding topology53,57-62 are believed to have arisen via 
divergent evolution from a common ancestor or a limited number of 
progenitor enzymes.53,60,63-67 Many aldolases share this fold with 
members of the enolase and NAL superfamilies, as well as sharing a 
similar mechanistic theme, i.e., the formation of a “masked” 
carbanionic intermediate (Scheme 3). Formation of such an 
intermediate is facilitated via formation of an imine/enamine “electron 
sink” with an active site lysine residue in the class I aldolases, and by 
utilizing a transition metal ion (usually Zn2+) as an essential Lewis acid 
cofactor in the class II aldolases. Although the reaction mechanisms 
differ between these two classes of aldolases, their ancestral aldolase 
has been postulated to have been a Schiff-base-forming enzyme that 
subsequently gave rise to a lineage of metal-dependent class II 
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aldolases.53 Several comparisons of sequences, structures, and 
functions have suggested common ancestry between the class I and II 
aldolases and the enolase superfamily.53,57,63,67 Considering the metal 
ion dependence of the class II aldolases, the mechanistic link to the 
enolase superfamily was clear (Scheme 3),68 but such a link between 
the class I aldolases and the enolase superfamily was not evident. 
Allen and co-workers conducted a comparison of the primary and 
tertiary structures of class I aldolases and members of the NAL 
superfamily, and concluded that these enzymes could all be included in 
a large superfamily utilizing Schiff-base chemistry and related by 
divergent evolution from a common progenitor enzyme.69 
Interestingly, these authors employed MR as a “negative control” 
because it was deemed not to be mechanistically related to the 
aldolases. This study suggests that a mechanistic relationship does 
indeed exist. Thus, while over evolutionary time scales the catalytic 
mechanism of enzymes may not be fully conserved,67 the ability of MR 
to form and deprotonate a Schiff-base intermediate furnishes a 
mechanistic link to other α/β-barrel enzymes utilizing Schiff-base 
chemistry and may be a relic of an activity possessed by a 
promiscuous progenitor enzyme.70 Delineating such chemistry-based 
relationships and their overlap with structure space and sequence 
space affords a more complete understanding of nature’s strategies for 
the evolution of new catalysts.3 
 
Scheme 3. Summary of the Reactions Catalyzed by the Enolase and NAL 
Superfamilies and the Class I and II Aldolases 
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Accession Codes 
The atomic coordinates of the 3-HP–MR structure have been deposited 
in the Protein Data Bank as entry 4X2P. 
Funding Information 
This work was supported by a Discovery Grant from the Natural 
Sciences and Engineering Research Council (NSERC) of Canada 
(S.L.B.) and National Science Foundation MRI-R2 Grant DBI-0959442 
(M.St.M.). Use of the Advanced Photon Source was supported by U.S. 
Department of Energy, Office of Science, Office of Basic Energy 
Sciences, under Contract DE-AC02-06CH11357. Use of LS-CAT Sector 
21 was supported by the Michigan Economic Development Corp. and 
the Michigan Technology Tri-Corridor for the support of this research 
program (Grant 085P1000817). B.N.W. was supported by a GAANN 
award (Graduate Assistance in Areas of National Need) from the U.S. 
Department of Education. 
The authors declare no competing financial interest. 
Acknowledgment 
We thank Alejandro Cohen of the Dalhousie Faculty of Medicine 
Proteomics Core Facility for his assistance in conducting and analyzing 
LC–ESI-MS/MS data. 
Abbreviations 
 
BzH benzohydroxamate 
CD circular dichroism 
DHDPS dihydrodipicolinate synthase 
ESI electrospray ionization 
3-FP 3-fluoropyruvate 
3-HP 3-hydroxypyruvate 
3-HP–MR wild-type MR modified by 3-HP 
LC liquid chromatography 
MR mandelate racemase 
MS mass spectrometry 
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NAL N-acetylneuraminate lyase 
TFHTP 3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propanoate. 
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Supplementary Figure 1S.  Competitive inhibition of MR by mesoxalate (Mox).  (A) 
Representative Lineweaver-Burk plot.  (B) Replot of the apparent Km/Vmax values against 
inhibitor concentration.  Assay conditions are as described in the Materials and Methods. 
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Supplementary Figure 2S.  Competitive inhibition of MR by 3-fluoropyruvate (3-FP).  (A) 
Representative Lineweaver-Burk plot.  (B) Replot of the apparent Km/Vmax values against 
inhibitor concentration.  Assay conditions are as described in the Materials and Methods. 
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Supplementary Figure 3S.  Time-dependence for the inhibition of MR by α-keto acids.  
Pyruvate (Pyr), mesoxalate (Mox), benzoylformate (BzF), and 3-fluoropyruvate (3-FP) do not 
show significant reduction in MR activity when incubated at concentrations of 2 mM with wild-
type MR for 10 min at 25 °C. 
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Supplementary Figure 4S.  Stereoview of a representative 2Fo-Fc electron density map, 
contoured at 1.0 σ, for the active site of 3-HP-MR.  The Brønsted acid-base catalysts (His 297 
and Lys 166) are colored cyan and the 3-HP adduct is colored green.   
 
